Avantor, Inc. (AVTR) is a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries. The company operates in more than 30 countries and delivers an extensive portfolio of products and services to customers around the globe, from the discovery stage of the Biopharma R&D process to the production stage.
Founded in 1904, Avantor is a Fortune 500 company headquartered in Radnor, Pennsylvania. The company specializes in providing proprietary branded products for the life sciences and advanced technologies sectors. Their operations focus on three business segments: Life Sciences - Americas, Life Sciences - EMEA, and Life Sciences - APAC. These segments offer materials and consumables, equipment and instrumentation, and services and specialty procurement for universities, medical research institutions, biotechnology and pharmaceutical companies, and industrial R&D departments.
Avantor has dedicated itself to setting science in motion to create a better world. They have established their position as trusted, collaborative partners in scientific research, with a commitment to accelerating customer performance and innovation through technology. Avantor's innovative services and range of products accommodate the full spectrum of scientific research in critical areas like bio-pharma, healthcare, education, and government, as well as applied research and advanced technologies.
The company's renowned product line encompasses over six million products, sourced from thousands of manufacturers across the globe. These include a broad range of chemicals, reagents, consumables, durable instruments, and disposable supplies. It also offers mission-critical products that help its customers in developing and manufacturing complex drug therapies, as well as innovative technologies for enhancing the production processes.
In addition to its product portfolio, Avantor offers a suite of various services such as procurement and sourcing, material management and logistics, and on-site services. These services are designed to consolidate and streamline the buying process for customers while ensuring that products are delivered efficiently and on time.
In 2019, Avantor went public through an initial public offering (IPO) on the New York Stock Exchange (NYSE). The launch was one of the largest healthcare IPOs of the year, with the company being valued at nearly $7.2 billion.
With its commitment to innovation, customer service, and quality, Avantor remains a leading player in the global life sciences and advanced technologies industries. Its strong reputation and its dedication to supplying a diverse range of products and services have positioned it as a trusted partner for scientific research and industrial applications worldwide. Avantor continues to maintain its focus on discovery and innovation in the field, driving value for both its clients and its shareholders.